Outcomes of Proactive Management of Children With Myelomeningocele

Launched by ASSIUT UNIVERSITY · Mar 4, 2024

Keywords

ClinConnect Summary

This clinical trial is studying a proactive approach to managing children with myelomeningocele (MMC), a severe form of spina bifida that can affect bladder function. The aim is to see how early treatment, such as using clean intermittent catheterization (a method of emptying the bladder) and medications, can help protect the kidneys and reduce problems like urinary incontinence. Children with MMC who are being treated at Assiut University Urology Hospital in Egypt may be eligible to participate in this trial, as long as they do not have other specific urinary conditions.

Participants in the trial will receive care from a team of specialists, including doctors who focus on the brain and spine, bones, and bladder health. This team approach is believed to provide better support for managing the complex needs of children with spina bifida. If you or someone you know has a child with myelomeningocele, this trial could offer a chance to receive comprehensive care aimed at improving their health and quality of life.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • all patients with myelomeningocele attending Assiut university urology hospital.
• Exclusion Criteria:
• • Associated other urological congenital anomalies (e.g., PUV or bladder exstrophy)